News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
News Features THT 2023 The Promise of AI for Improving Health Equity in Heart Failure Todd Neale April 04, 2023
News Features A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts Shelley Wood July 07, 2022
News Features As US Abortion Protections Are Lost, Cardiologists Brace for Impact Todd Neale June 24, 2022
News Features COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention Michael O'Riordan April 24, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Features Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training Shelley Wood January 01, 2019
News Features Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016 Caitlin E. Cox March 21, 2016
News Features Future of Renal Denervation May Hinge on a Handful of Small Studies Todd Neale February 14, 2016
News Features TCT 2014 Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease Todd Neale October 31, 2014
News Features Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3 June 24, 2014